• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Vitamin D Analog
    2 Drugs classified under this drug class


    All the Drug Class Drugs

    Betacalcip Teva
    Teva
    RX
    full basket chart
    Multiple ingredients
    Betacalcip Teva

    Corticosteroid, Vitamin D Analog. Calcipotriol 50 mcg/g, Betamethasone (as dipropionate) 0.5 mg/g.
    Oint:30/60/120 g. Apply to affected area once daily. The recomm. tmt. period is 4 wks. There is experience with repeated courses up to 52 w ks. If it is necessary to cont. or restart tmt. after 4 wks., tmt. should be cont. after med. review and under regular med. supervis.
    When using calcipotriol contain. med. products, the max. dly. dose should not exceed 15 g. The body surface area treated with calcipotriol contain. drugs  should not exceed 30% . See lit.
    Topical treatment of stable plaque

    psoriasis vulgaris amenable to topical

    therapy. For renal /hepatic impair. and  ped. pop. see lit.
    C/I: Hypersens. Pts with  erythrodermic, exfoliative and pustular psoriasis.
    Pts. with  known disorders of calcium metabolism .
    Pts. with viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds.

    Daivobet
    Dexcel
    RX
    partial basket chart
    Multiple ingredients
    Daivobet

    Corticosteroid, Vitamin D Analog. Betamethasone (as dipropionate) 0.5 mg/g, Calcipotriol (as hydrate) 50 mcg/g.
    OINT.: 30, 60gr.  Oint. should be applied to the affect. area once dly.
    The recomm. tmt. period is 4 wks. There is experience with repeated courses of Daivobet up to 52 w ks. If it is necessary to cont. or restart tmt. after 4 wks., tmt. should be cont.after med.review and under regular med. supervis.
    When using calcipotriol contain. med. products, the max. dly. dose should not exceed 15 g. The body surface area treated with calcipotriol contain. med. products should not exceed 30% . See lit.
    Topical tmt.  of stable plaque psoriasis vulgaris amenable to topical ther.
    C/I: Hypersens.
    Pts with  erythrodermic, exfoliative and pustular psoriasis.
    Pts. with  known disorders of calcium metabolism .
    Pts. with viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds.

     

    CLOSE